Covis Pharma (18 Drug Portfolio) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Covis Pharma (18 Drug Portfolio) General Information

Description

18 drug portfolio of Covis Pharma. The portfolio includes branded pharmaceuticals, injectables and authorized generics that address life threatening and other serious medical conditions in various therapeutic areas including cardiovascular, central nervous system, oncology and acute care markets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • 1513 Walnut Street
  • Suite 270
  • Cary, NC 27511
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Covis Pharma (18 Drug Portfolio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Covis Pharma (18 Drug Portfolio)‘s full profile, request access.

Request a free trial

Covis Pharma (18 Drug Portfolio) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Covis Pharma (18 Drug Portfolio)‘s full profile, request access.

Request a free trial